SCIENTISTS in Germany who developed a new way to make a key malaria drug several years ago said they have come up with a technique to make the process even more efficient, which should increase global access and reduce the cost.
The new procedure refines a method developed in 2012 at the Max Planck Institute to use the waste product from the production of artemisinin, which is extracted from a plant known as sweet wormwood, to create the drug itself.
That involved a new machine which could convert about 40 per cent of waste acid into artemisinin, producing more of the drug from what had previously been binned.
The new procedure uses the plant’s own chlorophyll instead of additional chemicals as catalysts to drive the reaction, directly using the crude materials to produce the drug more efficiently.
Peter Seeberger, director of the Max Planck Institute unit working on the issue, said the development has the potential to save millions of lives by increasing the global access and reducing the cost of anti-malaria medicine.
The World Health Organisation reported that there were 216 million malaria cases worldwide in 2016, up by five million over 2015, and 445,000 people died of the disease, primarily children.
Chemist Kerry Gilmore said: “We’re able to get much more out of the plant than ever before.
“The process we have now is more efficient and significantly cheaper than what we had in 2012.”
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here